X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/09/20/2746463/0/en/Protara-Therapeutics-Announces-Dosing-of-First-Patient-in-Phase-1b-2-ADVANCED-2-Trial-of-TARA-002-in-NMIBC-Patients-with-High-Grade-Carcinoma-in-Situ.html
https://www.globenewswire.com//news-release/2023/09/05/2737202/0/en/Protara-Therapeutics-to-Present-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html
https://www.globenewswire.com/news-release/2023/08/03/2717953/0/en/Protara-Therapeutics-Announces-Second-Quarter-2023-Financial-Results-and-Business-Update.html
https://www.clinicaltrialsarena.com/news/protara-phase-ib-advanced-1exp/
https://www.globenewswire.com/news-release/2023/05/15/2668718/0/en/Protara-Therapeutics-Announces-Dosing-of-First-Patients-in-Phase-1b-ADVANCED-1EXP-Trial-of-TARA-002-in-NMIBC-Patients-with-Carcinoma-in-Situ.html
https://www.globenewswire.com/news-release/2023/05/04/2661432/0/en/Protara-Therapeutics-Announces-First-Quarter-2023-Financial-Results-and-Business-Update.html
https://www.globenewswire.com/news-release/2023/05/02/2659069/0/en/Protara-Therapeutics-Receives-Regulatory-Clearance-from-FDA-to-Commence-Phase-2-STARBORN-1-Trial-of-TARA-002-in-Pediatric-Patients-with-Lymphatic-Malformations.html
https://www.globenewswire.com/news-release/2023/03/08/2622963/0/en/Protara-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2023/03/01/2618113/0/en/Protara-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2023/02/02/2600388/0/en/Protara-Therapeutics-to-Present-at-the-Guggenheim-Healthcare-Talks-Oncology-Day.html
Market Place
Share 
